Literature DB >> 24381646

The role of obesity in gastrointestinal cancer: evidence and opinion.

Claire L Donohoe1, Naoimh J O'Farrell1, Suzanne L Doyle1, John V Reynolds2.   

Abstract

There is increasing recognition of the impact of being overweight and obese on the development of cancers at diverse sites including the gastrointestinal tract. Large epidemiological studies indicate that up to 14% of tumours may be related to obesity. Pathophysiological mechanisms underpinning this association are not well understood and so are discussed in this review.

Entities:  

Keywords:  adipose tissue, carcinogenesis; inflammation; signalling pathways; visceral adiposity

Year:  2014        PMID: 24381646      PMCID: PMC3871278          DOI: 10.1177/1756283X13501786

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  126 in total

Review 1.  Overweight prevalence among youth in the United States: why so many different numbers?

Authors:  R P Troiano; K M Flegal
Journal:  Int J Obes Relat Metab Disord       Date:  1999-03

Review 2.  Insulin resistance--mechanisms, syndromes, and implications.

Authors:  D E Moller; J S Flier
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

3.  Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling.

Authors:  Santosh K Katiyar; Syed M Meeran
Journal:  Free Radic Biol Med       Date:  2006-10-28       Impact factor: 7.376

4.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

5.  Association between body mass and adenocarcinoma of the esophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; O Nyrén
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

6.  Trends in obesity and abdominal obesity among adults in the United States from 1999-2008.

Authors:  E S Ford; C Li; G Zhao; J Tsai
Journal:  Int J Obes (Lond)       Date:  2010-09-07       Impact factor: 5.095

7.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

Review 8.  Adipokines: inflammation and the pleiotropic role of white adipose tissue.

Authors:  Paul Trayhurn; I Stuart Wood
Journal:  Br J Nutr       Date:  2004-09       Impact factor: 3.718

9.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

10.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

Authors:  Ebba Bråkenhielm; Niina Veitonmäki; Renhai Cao; Shinji Kihara; Yuji Matsuzawa; Boris Zhivotovsky; Tohru Funahashi; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  14 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocarcinoma.

Authors:  Christophe Van de Wiele; Mathias Van Vlaenderen; Ludovic D'Hulst; Anne Delcourt; Dominique Copin; Bart De Spiegeleer; Alex Maes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-11       Impact factor: 9.236

3.  Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.

Authors:  Chang Geun Lee; Jun Kyu Lee; Yun-Seong Kang; Seungmin Shin; Jae Hak Kim; Yun Jeong Lim; Moon-Soo Koh; Jin Ho Lee; Hyoun Woo Kang
Journal:  Am J Gastroenterol       Date:  2015-01-13       Impact factor: 10.864

Review 4.  Gastroesophageal Cancer After Gastric Bypass Surgeries: a Systematic Review and Meta-analysis.

Authors:  Rodrigue Chemaly; Samer Diab; Georges Khazen; Georges Al-Hajj
Journal:  Obes Surg       Date:  2022-01-27       Impact factor: 4.129

Review 5.  Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma.

Authors:  Leo Alexandre; Elizabeth Long; Ian Lp Beales
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 6.  The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials.

Authors:  Cian O Malley; Graham P Pidgeon
Journal:  BBA Clin       Date:  2015-11-12

7.  Analysis of the Human Proteome in Subcutaneous and Visceral Fat Depots in Diabetic and Non-diabetic Patients with Morbid Obesity.

Authors:  Lingling Fang; Kyoko Kojima; Lihua Zhou; David K Crossman; James A Mobley; Jayleen Grams
Journal:  J Proteomics Bioinform       Date:  2015-06-08

Review 8.  Role of tumor microenvironment in tumorigenesis.

Authors:  Maonan Wang; Jingzhou Zhao; Lishen Zhang; Fang Wei; Yu Lian; Yingfeng Wu; Zhaojian Gong; Shanshan Zhang; Jianda Zhou; Ke Cao; Xiayu Li; Wei Xiong; Guiyuan Li; Zhaoyang Zeng; Can Guo
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

9.  Anti-Adipogenic Effect of Neferine in 3T3-L1 Cells and Primary White Adipocytes.

Authors:  Miey Park; Jinyoung Han; Hae-Jeung Lee
Journal:  Nutrients       Date:  2020-06-22       Impact factor: 5.717

Review 10.  Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.

Authors:  Claudia Sanna; Chiara Rosso; Milena Marietti; Elisabetta Bugianesi
Journal:  Int J Mol Sci       Date:  2016-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.